Cover of The antidote

Business & EconomicsHistory

The antidote

Rating
4.00
1 rating
Pages
448
3 editions
First published
2014
1 language

Overview

In 1989, the charismatic Joshua Boger left Merck, then America's most admired business, to found a drug company that would challenge industry giants and transform health care. Journalist Barry Werth described the company's tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell the story of Vertex's bold endurance and eventual success. The pharmaceutical business is America's toughest and one of its most profitable. It's riskier and more rigorous at just about every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine; to the multibillion-dollar cost of ramping up a successful product; to operating in the world's most regulated industry, matched only by nuclear power. Werth captures the full scope of Vertex's 25-year drive to deliver breakthrough medicines.--From publisher description.

Ratings & reviews

Log in to rate or review this book.

No written reviews yet.

Discussions

Talk about this book with other readers.

Log in to start a discussion.

No discussions yet.

Editions

  • Format not known Simon & Schuster 2014 435 pages English ISBN 9781451655667 Open Library
  • Format not known Simon & Schuster, Limited 2014 448 pages English ISBN 9781451655698 Open Library
  • Paperback Simon & Schuster 2014 448 pages ISBN 9781451655674 Open Library

Details & links

First published
2014
Pages
448
Languages
Available in 1 language

Where to buy this book: see “Buy this book”

More about this book

See it on Goodreads →

Read a sample, borrow it or see other editions → openlibrary.org

Same series, author or genres